drugset / Trial / NCT00869336

Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot)

NCT00869336

Phase 2 Completed 147 enrolled Tinea Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To examine the safety and optimal duration of Luliconazole Cream 1% treatments for 14 days or 28 days to achieve "complete clearance" at 2 weeks post treatment.

Timeline

Start
2009-03
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Luliconazole Small molecule 1 % Topical

Indications